User profiles for "author:Angela Dispenzieri"
Angela DispenzieriMayo Clinic Verified email at mayo.edu Cited by 105011 |
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
Summary This International Myeloma Working Group consensus updates the disease
definition of multiple myeloma to include validated biomarkers in addition to existing …
definition of multiple myeloma to include validated biomarkers in addition to existing …
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
The serum immunoglobulin-free light chain (FLC) assay measures levels of free κ and λ
immunoglobulin light chains. There are three major indications for the FLC assay in the …
immunoglobulin light chains. There are three major indications for the FLC assay in the …
IMWG consensus on risk stratification in multiple myeloma
Multiple myeloma is characterized by underlying clinical and biological heterogeneity, which
translates to variable response to treatment and outcome. With the recent increase in …
translates to variable response to treatment and outcome. With the recent increase in …
Review of 1027 patients with newly diagnosed multiple myeloma
Objective To determine the clinical and laboratory features of newly diagnosed multiple
myeloma. Patients and Methods Records of all patients in whom multiple myeloma was …
myeloma. Patients and Methods Records of all patients in whom multiple myeloma was …
Improved survival in multiple myeloma and the impact of novel therapies
Treatments for myeloma have expanded in the last decade, but it is not clear if the
introduction of novel therapies and the increased use of high-dose therapy have translated …
introduction of novel therapies and the increased use of high-dose therapy have translated …
[PDF][PDF] Promiscuous mutations activate the noncanonical NF-κB pathway in multiple myeloma
Activation of NF-κB has been noted in many tumor types, however only rarely has this been
linked to an underlying genetic mutation. An integrated analysis of high-density …
linked to an underlying genetic mutation. An integrated analysis of high-density …
Nonbiopsy diagnosis of cardiac transthyretin amyloidosis
Background—Cardiac transthyretin (ATTR) amyloidosis is a progressive and fatal
cardiomyopathy for which several promising therapies are in development. The diagnosis is …
cardiomyopathy for which several promising therapies are in development. The diagnosis is …
[HTML][HTML] Prevalence of monoclonal gammopathy of undetermined significance
RA Kyle, TM Therneau, SV Rajkumar… - … England Journal of …, 2006 - Mass Medical Soc
Background The prevalence of monoclonal gammopathy of undetermined significance
(MGUS), a premalignant plasma-cell disorder, among persons 50 years of age or older has …
(MGUS), a premalignant plasma-cell disorder, among persons 50 years of age or older has …
Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
Therapy for multiple myeloma (MM) has markedly changed in the past decade with the
introduction of new drugs, but it is not clear whether the improvements have been sustained …
introduction of new drugs, but it is not clear whether the improvements have been sustained …
Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant plasma-
cell proliferative disorder associated with a life-long risk of progression to multiple myeloma …
cell proliferative disorder associated with a life-long risk of progression to multiple myeloma …